1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biguanides
1.2.3 Sulphonylureas
1.2.4 Thiazolidinediones
1.2.5 Alpha-glucosidase Inhibitors
1.2.6 DPP-4 Inhibitors
1.2.7 GLP-1 Receptor Agonists
1.2.8 SGLT-2 Inhibitors
1.2.9 Insulins
1.3 Market by Application
1.3.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Type 2 Diabetes Medication Market Perspective (2017-2028)
2.2 Type 2 Diabetes Medication Growth Trends by Region
2.2.1 Type 2 Diabetes Medication Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Type 2 Diabetes Medication Historic Market Size by Region (2017-2022)
2.2.3 Type 2 Diabetes Medication Forecasted Market Size by Region (2023-2028)
2.3 Type 2 Diabetes Medication Market Dynamics
2.3.1 Type 2 Diabetes Medication Industry Trends
2.3.2 Type 2 Diabetes Medication Market Drivers
2.3.3 Type 2 Diabetes Medication Market Challenges
2.3.4 Type 2 Diabetes Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type 2 Diabetes Medication Players by Revenue
3.1.1 Global Top Type 2 Diabetes Medication Players by Revenue (2017-2022)
3.1.2 Global Type 2 Diabetes Medication Revenue Market Share by Players (2017-2022)
3.2 Global Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type 2 Diabetes Medication Revenue
3.4 Global Type 2 Diabetes Medication Market Concentration Ratio
3.4.1 Global Type 2 Diabetes Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medication Revenue in 2021
3.5 Type 2 Diabetes Medication Key Players Head office and Area Served
3.6 Key Players Type 2 Diabetes Medication Product Solution and Service
3.7 Date of Enter into Type 2 Diabetes Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type 2 Diabetes Medication Breakdown Data by Type
4.1 Global Type 2 Diabetes Medication Historic Market Size by Type (2017-2022)
4.2 Global Type 2 Diabetes Medication Forecasted Market Size by Type (2023-2028)
5 Type 2 Diabetes Medication Breakdown Data by Application
5.1 Global Type 2 Diabetes Medication Historic Market Size by Application (2017-2022)
5.2 Global Type 2 Diabetes Medication Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Type 2 Diabetes Medication Market Size (2017-2028)
6.2 North America Type 2 Diabetes Medication Market Size by Type
6.2.1 North America Type 2 Diabetes Medication Market Size by Type (2017-2022)
6.2.2 North America Type 2 Diabetes Medication Market Size by Type (2023-2028)
6.2.3 North America Type 2 Diabetes Medication Market Share by Type (2017-2028)
6.3 North America Type 2 Diabetes Medication Market Size by Application
6.3.1 North America Type 2 Diabetes Medication Market Size by Application (2017-2022)
6.3.2 North America Type 2 Diabetes Medication Market Size by Application (2023-2028)
6.3.3 North America Type 2 Diabetes Medication Market Share by Application (2017-2028)
6.4 North America Type 2 Diabetes Medication Market Size by Country
6.4.1 North America Type 2 Diabetes Medication Market Size by Country (2017-2022)
6.4.2 North America Type 2 Diabetes Medication Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Type 2 Diabetes Medication Market Size (2017-2028)
7.2 Europe Type 2 Diabetes Medication Market Size by Type
7.2.1 Europe Type 2 Diabetes Medication Market Size by Type (2017-2022)
7.2.2 Europe Type 2 Diabetes Medication Market Size by Type (2023-2028)
7.2.3 Europe Type 2 Diabetes Medication Market Share by Type (2017-2028)
7.3 Europe Type 2 Diabetes Medication Market Size by Application
7.3.1 Europe Type 2 Diabetes Medication Market Size by Application (2017-2022)
7.3.2 Europe Type 2 Diabetes Medication Market Size by Application (2023-2028)
7.3.3 Europe Type 2 Diabetes Medication Market Share by Application (2017-2028)
7.4 Europe Type 2 Diabetes Medication Market Size by Country
7.4.1 Europe Type 2 Diabetes Medication Market Size by Country (2017-2022)
7.4.2 Europe Type 2 Diabetes Medication Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type 2 Diabetes Medication Market Size (2017-2028)
8.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type
8.2.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Type 2 Diabetes Medication Market Share by Type (2017-2028)
8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Application
8.3.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Type 2 Diabetes Medication Market Share by Application (2017-2028)
8.4 Asia-Pacific Type 2 Diabetes Medication Market Size by Region
8.4.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Type 2 Diabetes Medication Market Size (2017-2028)
9.2 Latin America Type 2 Diabetes Medication Market Size by Type
9.2.1 Latin America Type 2 Diabetes Medication Market Size by Type (2017-2022)
9.2.2 Latin America Type 2 Diabetes Medication Market Size by Type (2023-2028)
9.2.3 Latin America Type 2 Diabetes Medication Market Share by Type (2017-2028)
9.3 Latin America Type 2 Diabetes Medication Market Size by Application
9.3.1 Latin America Type 2 Diabetes Medication Market Size by Application (2017-2022)
9.3.2 Latin America Type 2 Diabetes Medication Market Size by Application (2023-2028)
9.3.3 Latin America Type 2 Diabetes Medication Market Share by Application (2017-2028)
9.4 Latin America Type 2 Diabetes Medication Market Size by Country
9.4.1 Latin America Type 2 Diabetes Medication Market Size by Country (2017-2022)
9.4.2 Latin America Type 2 Diabetes Medication Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type 2 Diabetes Medication Market Size (2017-2028)
10.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type
10.2.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Type 2 Diabetes Medication Market Share by Type (2017-2028)
10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Application
10.3.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Type 2 Diabetes Medication Market Share by Application (2017-2028)
10.4 Middle East & Africa Type 2 Diabetes Medication Market Size by Country
10.4.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Type 2 Diabetes Medication Introduction
11.1.4 AstraZeneca Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Type 2 Diabetes Medication Introduction
11.2.4 Novartis Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Type 2 Diabetes Medication Introduction
11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.3.5 Novo Nordisk Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Type 2 Diabetes Medication Introduction
11.4.4 Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Introduction
11.5.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Introduction
11.6.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Type 2 Diabetes Medication Introduction
11.7.4 Eli Lilly Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.7.5 Eli Lilly Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Type 2 Diabetes Medication Introduction
11.8.4 Merck Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Type 2 Diabetes Medication Introduction
11.9.4 Sanofi Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.9.5 Sanofi Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Type 2 Diabetes Medication Introduction
11.10.4 Pfizer Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.10.5 Pfizer Recent Developments
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Details
11.11.2 Astellas Pharma Business Overview
11.11.3 Astellas Pharma Type 2 Diabetes Medication Introduction
11.11.4 Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.11.5 Astellas Pharma Recent Developments
11.12 Daiichi Sankyo
11.12.1 Daiichi Sankyo Company Details
11.12.2 Daiichi Sankyo Business Overview
11.12.3 Daiichi Sankyo Type 2 Diabetes Medication Introduction
11.12.4 Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.12.5 Daiichi Sankyo Recent Developments
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Type 2 Diabetes Medication Introduction
11.13.4 Biocon Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.13.5 Biocon Recent Developments
11.14 Glenmark
11.14.1 Glenmark Company Details
11.14.2 Glenmark Business Overview
11.14.3 Glenmark Type 2 Diabetes Medication Introduction
11.14.4 Glenmark Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.14.5 Glenmark Recent Developments
11.15 Bayer AG
11.15.1 Bayer AG Company Details
11.15.2 Bayer AG Business Overview
11.15.3 Bayer AG Type 2 Diabetes Medication Introduction
11.15.4 Bayer AG Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.15.5 Bayer AG Recent Developments
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Type 2 Diabetes Medication Introduction
11.16.4 Takeda Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.16.5 Takeda Recent Developments
11.17 Sun pharma
11.17.1 Sun pharma Company Details
11.17.2 Sun pharma Business Overview
11.17.3 Sun pharma Type 2 Diabetes Medication Introduction
11.17.4 Sun pharma Revenue in Type 2 Diabetes Medication Business (2017-2022)
11.17.5 Sun pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Type 2 Diabetes Medication Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Biguanides
Table 3. Key Players of Sulphonylureas
Table 4. Key Players of Thiazolidinediones
Table 5. Key Players of Alpha-glucosidase Inhibitors
Table 6. Key Players of DPP-4 Inhibitors
Table 7. Key Players of GLP-1 Receptor Agonists
Table 8. Key Players of SGLT-2 Inhibitors
Table 9. Key Players of Insulins
Table 10. Global Type 2 Diabetes Medication Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global Type 2 Diabetes Medication Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Type 2 Diabetes Medication Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Type 2 Diabetes Medication Market Share by Region (2017-2022)
Table 14. Global Type 2 Diabetes Medication Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Type 2 Diabetes Medication Market Share by Region (2023-2028)
Table 16. Type 2 Diabetes Medication Market Trends
Table 17. Type 2 Diabetes Medication Market Drivers
Table 18. Type 2 Diabetes Medication Market Challenges
Table 19. Type 2 Diabetes Medication Market Restraints
Table 20. Global Type 2 Diabetes Medication Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Type 2 Diabetes Medication Revenue Share by Players (2017-2022)
Table 22. Global Top Type 2 Diabetes Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2021)
Table 23. Ranking of Global Top Type 2 Diabetes Medication Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Type 2 Diabetes Medication Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Type 2 Diabetes Medication Product Solution and Service
Table 27. Date of Enter into Type 2 Diabetes Medication Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Type 2 Diabetes Medication Revenue Market Share by Type (2017-2022)
Table 31. Global Type 2 Diabetes Medication Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Type 2 Diabetes Medication Revenue Market Share by Type (2023-2028)
Table 33. Global Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Type 2 Diabetes Medication Revenue Share by Application (2017-2022)
Table 35. Global Type 2 Diabetes Medication Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Type 2 Diabetes Medication Revenue Share by Application (2023-2028)
Table 37. North America Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
Table 38. North America Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
Table 39. North America Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
Table 40. North America Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
Table 41. North America Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
Table 42. North America Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
Table 43. Europe Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
Table 44. Europe Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
Table 45. Europe Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
Table 46. Europe Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
Table 47. Europe Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
Table 48. Europe Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
Table 49. Asia Pacific Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
Table 50. Asia Pacific Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
Table 51. Asia Pacific Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
Table 52. Asia Pacific Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
Table 53. Asia Pacific Type 2 Diabetes Medication Market Size by Region (2017-2022) & (US$ Million)
Table 54. Asia Pacific Type 2 Diabetes Medication Market Size by Region (2023-2028) & (US$ Million)
Table 55. Latin America Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
Table 56. Latin America Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
Table 57. Latin America Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
Table 58. Latin America Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
Table 59. Latin America Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
Table 60. Latin America Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Type 2 Diabetes Medication Product
Table 70. AstraZeneca Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 71. AstraZeneca Recent Developments
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Type 2 Diabetes Medication Product
Table 75. Novartis Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 76. Novartis Recent Developments
Table 77. Novo Nordisk Company Details
Table 78. Novo Nordisk Business Overview
Table 79. Novo Nordisk Type 2 Diabetes Medication Product
Table 80. Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 81. Novo Nordisk Recent Developments
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Type 2 Diabetes Medication Product
Table 85. Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 86. Johnson & Johnson Recent Developments
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Type 2 Diabetes Medication Product
Table 90. Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Developments
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Type 2 Diabetes Medication Product
Table 95. Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Developments
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Type 2 Diabetes Medication Product
Table 100. Eli Lilly Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 101. Eli Lilly Recent Developments
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Type 2 Diabetes Medication Product
Table 105. Merck Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 106. Merck Recent Developments
Table 107. Sanofi Company Details
Table 108. Sanofi Business Overview
Table 109. Sanofi Type 2 Diabetes Medication Product
Table 110. Sanofi Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 111. Sanofi Recent Developments
Table 112. Pfizer Company Details
Table 113. Pfizer Business Overview
Table 114. Pfizer Type 2 Diabetes Medication Product
Table 115. Pfizer Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 116. Pfizer Recent Developments
Table 117. Astellas Pharma Company Details
Table 118. Astellas Pharma Business Overview
Table 119. Astellas Pharma Type 2 Diabetes Medication Product
Table 120. Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 121. Astellas Pharma Recent Developments
Table 122. Daiichi Sankyo Company Details
Table 123. Daiichi Sankyo Business Overview
Table 124. Daiichi Sankyo Type 2 Diabetes Medication Product
Table 125. Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 126. Daiichi Sankyo Recent Developments
Table 127. Biocon Company Details
Table 128. Biocon Business Overview
Table 129. Biocon Type 2 Diabetes Medication Product
Table 130. Biocon Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 131. Biocon Recent Developments
Table 132. Glenmark Company Details
Table 133. Glenmark Business Overview
Table 134. Glenmark Type 2 Diabetes Medication Product
Table 135. Glenmark Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 136. Glenmark Recent Developments
Table 137. Bayer AG Company Details
Table 138. Bayer AG Business Overview
Table 139. Bayer AG Type 2 Diabetes Medication Product
Table 140. Bayer AG Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 141. Bayer AG Recent Developments
Table 142. Takeda Company Details
Table 143. Takeda Business Overview
Table 144. Takeda Type 2 Diabetes Medication Product
Table 145. Takeda Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 146. Takeda Recent Developments
Table 147. Sun pharma Company Details
Table 148. Sun pharma Business Overview
Table 149. Sun pharma Type 2 Diabetes Medication Product
Table 150. Sun pharma Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
Table 151. Sun pharma Recent Developments
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type 2 Diabetes Medication Market Share by Type: 2021 VS 2028
Figure 2. Biguanides Features
Figure 3. Sulphonylureas Features
Figure 4. Thiazolidinediones Features
Figure 5. Alpha-glucosidase Inhibitors Features
Figure 6. DPP-4 Inhibitors Features
Figure 7. GLP-1 Receptor Agonists Features
Figure 8. SGLT-2 Inhibitors Features
Figure 9. Insulins Features
Figure 10. Global Type 2 Diabetes Medication Market Share by Application: 2021 VS 2028
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Type 2 Diabetes Medication Report Years Considered
Figure 15. Global Type 2 Diabetes Medication Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Type 2 Diabetes Medication Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Type 2 Diabetes Medication Market Share by Region: 2021 VS 2028
Figure 18. Global Type 2 Diabetes Medication Market Share by Players in 2021
Figure 19. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medication Revenue in 2021
Figure 21. North America Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
Figure 23. North America Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
Figure 24. North America Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
Figure 25. United States Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
Figure 29. Europe Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
Figure 30. Europe Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
Figure 31. Germany Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Type 2 Diabetes Medication Market Size Share by Region (2017-2028)
Figure 41. China Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
Figure 51. Mexico Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
Figure 57. Turkey Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 62. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 63. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 66. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 67. Merck Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 68. Sanofi Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 69. Pfizer Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 70. Astellas Pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 71. Daiichi Sankyo Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 72. Biocon Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 73. Glenmark Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 74. Bayer AG Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 75. Takeda Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 76. Sun pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
